UNSPSC 85791316: Repair lymphatics and hemic in products of conception, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to repair lymphatics and hemic in products of conception, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 10Q00ZG

UNSPSC 85791316, Repair lymphatics and hemic in products of conception, open approach, is a Commodity code that shows no alignment between its nominal scope and the state and local opportunities recently tagged under it. The code's clinical description references obstetric surgical repair of lymphatic and blood system components, yet the recent solicitations it has attracted span occupational health surveillance, pharmacy benefit management, independent medical evaluations for pension disability determinations, surgical procedure carve-outs for municipal employee health plans, specialty medical services for detained youth, and temporary clinical staffing—none of which involve repair procedures on products of conception in any clinical sense. The mismatch suggests either a systematic miscoding by issuing bodies or that the code has drifted from its intended use in state and local procurement systems.

The issuing bodies include a state transportation department (Washington State Department of Transportation), county health systems and probation departments (Harris County Juvenile Probation Department, Santa Clara County Health System), municipal governments (City of Phoenix, City of Long Beach), and a county board of commissioners (Collier County, Florida). Recent opportunities range from Washington State Ferries' occupational medical surveillance RFP due October 9, 2026, to the City of Phoenix Retirement Office's independent medical evaluation services RFP due October 16, 2026 (maximum compensation $750,000 over five years), to Collier County's pharmacy benefit management RFP (historical annual spend approximately $8.7 million) with an April 9, 2026 deadline. The code shows no meaningful recent activity grounded in its stated clinical scope.